- Home
- VTVT vs LGL Comparison
VTVT vs LGL Comparison
Compare VTVT & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- LGL
- Stock Information
- Founded
- VTVT 2015
- LGL 1917
- Country
- VTVT United States
- LGL United States
- Employees
- VTVT N/A
- LGL N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- LGL Industrial Machinery/Components
- Sector
- VTVT Health Care
- LGL Technology
- Exchange
- VTVT Nasdaq
- LGL Nasdaq
- Market Cap
- VTVT 38.8M
- LGL 39.1M
- IPO Year
- VTVT 2015
- LGL N/A
- Fundamental
- Price
- VTVT $16.50
- LGL $6.32
- Analyst Decision
- VTVT Strong Buy
- LGL
- Analyst Count
- VTVT 1
- LGL 0
- Target Price
- VTVT $35.00
- LGL N/A
- AVG Volume (30 Days)
- VTVT 46.9K
- LGL 5.3K
- Earning Date
- VTVT 05-08-2025
- LGL 05-14-2025
- Dividend Yield
- VTVT N/A
- LGL N/A
- EPS Growth
- VTVT N/A
- LGL 66.76
- EPS
- VTVT N/A
- LGL 0.08
- Revenue
- VTVT $1,017,000.00
- LGL $4,292,000.00
- Revenue This Year
- VTVT N/A
- LGL N/A
- Revenue Next Year
- VTVT N/A
- LGL N/A
- P/E Ratio
- VTVT N/A
- LGL $81.63
- Revenue Growth
- VTVT N/A
- LGL 26.49
- 52 Week Low
- VTVT $12.12
- LGL $4.86
- 52 Week High
- VTVT $29.19
- LGL $7.28
- Technical
- Relative Strength Index (RSI)
- VTVT 46.27
- LGL 46.82
- Support Level
- VTVT $15.36
- LGL $6.17
- Resistance Level
- VTVT $17.86
- LGL $7.28
- Average True Range (ATR)
- VTVT 1.93
- LGL 0.47
- MACD
- VTVT -0.08
- LGL 0.00
- Stochastic Oscillator
- VTVT 15.61
- LGL 38.13
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.